Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (740)	12/17/2001 1:37:53 PM
From: RCMac	Read Replies (2) \| Respond to of 1025

If memory serves, IGEN had something like $100 million in tax loss carryforwards that expire at the end of this year. Tuck, The company's fiscal year is 3/31, so nothing will expire at 12/31/01, and I don't think any near expirations are anything like the magnitude of $100M. Here's the info on NOLCF's from the 6/29/01 10-K, at note 7 to the 3/31/01 financial statements (p. 42 of the hard copy): As of March 31, 2001, the Company has available for income tax reporting purposes net operating loss and general business credit carryforwards approximating $132 million and $3.9 million, respectively. These carryforwards expire in varying amounts through March 31, 2016. The use of the Company's net operating loss carryforward may be significantly reduced if substantial changes in stock ownership take place. Presumably two additional quarters of accounting losses, including heavy legal expenses, have increased the NOLCF's to $150 million or more. (I take it that the $3.9 million of "general business credit carryforwards" is a Maryland state tax item.) --RCM